Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$1.5 - $3.75 $1,372 - $3,431
915 Added 104.57%
1,790 $3,000
Q3 2023

Oct 30, 2023

BUY
$1.5 - $3.75 $1,372 - $3,431
915 Added 104.57%
1,790 $3,000
Q2 2023

May 21, 2024

SELL
$2.21 - $4.43 $39 - $79
-18 Reduced 2.02%
875 $2,000
Q2 2023

Jul 27, 2023

SELL
$2.21 - $4.43 $39 - $79
-18 Reduced 2.02%
875 $2,000
Q1 2023

May 21, 2024

BUY
$3.81 - $6.76 $857 - $1,521
225 Added 33.68%
893 $3,000
Q1 2023

Apr 27, 2023

BUY
$3.81 - $6.76 $857 - $1,521
225 Added 33.68%
893 $4,000
Q4 2022

May 21, 2024

BUY
$4.26 - $6.84 $2,845 - $4,569
668 New
668 $3,000
Q4 2022

Jan 31, 2023

BUY
$4.26 - $6.84 $234 - $376
55 Added 8.97%
668 $3,000
Q3 2022

Oct 21, 2022

BUY
$6.06 - $12.86 $3,714 - $7,883
613 New
613 $4,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.